Moderna to seek U.S. and EU authorisation for its COVID-19 vaccine following final results

Final results detail the Moderna vaccine has 94% efficacy (11 of 196 volunteers who contracted COVID-19 in the study had received the vaccine). It was also 100% effective in preventing severe cases (all of the 30 severe cases reported in the study were in the placebo group).

SPS commentary:

Moderna plans to start a new trial to test the vaccine in adolescents before the end of the year, followed by another in younger volunteers early in 2021.

Reuters Health